SEC Company Response from Twist Bioscience Corp (TWST) (CIK 0001581280) (TWST) — Dec 12, 2019
Twist Bioscience Corp (TWST) (CIK 0001581280)
Date: Dec. 12, 2019 · CIK: 0001581280 · Accession: 0001193125-19-313060
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-234538
Letter
TWIST BIOSCIENCE CORPORATION
681 Gateway Blvd.
South San Francisco, CA 94080
December 12, 2019
VIA EDGAR
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attn: Chris Edwards, Office of Life Sciences Irene Paik, Office of Life Sciences
Re: Twist Bioscience Corporation Acceleration Request
Acceleration Request
Requested Date:
December 13, 2019
Requested Time:
4:30 p.m. Eastern Time
Ladies and Gentlemen:
Twist Bioscience Corporation (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the Company’s Registration Statement on Form S-3 (File No. 333-234538), as amended, effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable.
The Company hereby authorizes Andrew D. Thorpe, who is an attorney with the Company’s outside legal counsel, Orrick, Herrington & Sutcliffe LLP, to orally modify or withdraw this request for acceleration.
The Company requests that it be notified of such effectiveness by a telephone call to Mr. Thorpe at (415) 773-5970.
[Signature page follows]
Sincerely,
TWIST BIOSCIENCE CORPORATION
Show Raw Text
CORRESP 1 filename1.htm CORRESP TWIST BIOSCIENCE CORPORATION 681 Gateway Blvd. South San Francisco, CA 94080 December 12, 2019 VIA EDGAR U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attn: Chris Edwards, Office of Life Sciences Irene Paik, Office of Life Sciences Re: Twist Bioscience Corporation Acceleration Request Acceleration Request Requested Date: December 13, 2019 Requested Time: 4:30 p.m. Eastern Time Ladies and Gentlemen: Twist Bioscience Corporation (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the Company’s Registration Statement on Form S-3 (File No. 333-234538), as amended, effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable. The Company hereby authorizes Andrew D. Thorpe, who is an attorney with the Company’s outside legal counsel, Orrick, Herrington & Sutcliffe LLP, to orally modify or withdraw this request for acceleration. The Company requests that it be notified of such effectiveness by a telephone call to Mr. Thorpe at (415) 773-5970. [Signature page follows] Sincerely, TWIST BIOSCIENCE CORPORATION By: /s/ Mark Daniels Name: Mark Daniels Title: Chief Legal Officer, Secretary and Chief Ethics and Compliance Officer cc: Emily M. Leproust, Ph.D., Twist Bioscience Corporation Andrew D. Thorpe, Esq., Orrick, Herrington & Sutcliffe, LLP Melissa V. Frayer, Esq., Orrick, Herrington & Sutcliffe, LLP